Ceapro Inc V.CZO

Alternate Symbol(s): CRPOF

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > AEZS Q4

<< Previous

Bullboard Posts

Next >>

Comment by prophetoffactzon Mar 27, 2024 10:59am

45 Views

Post# 35955424

RE:RE:AEZS Q4

lscfa wrote: A crummy $66,000 US in sales of products to European partner in Q4.

The analyst didn't have anything forcast for revenue in Q4. The estimate climbs to $1.1 million in Q1.

Aeterna Zentaris Inc. (AEZS) Analyst Ratings, Estimates & Forecasts - Yahoo Finance

This is a pediatric test in many markets. In the US it can also qualify for orphan pricing. If AEZS can establish its test as a standalone test it could be a game-changer. The pediatric trial is set up as a potential standalone. Currently two tests are generally required to diagnose growth hormone deficiency.

<< Previous

Bullboard Posts

Next >>

How to interpret movements in the price of gold